Baseline N-telopeptide levels correlate with risk of skeletal morbidity in patients with multiple myeloma during zoledronic acid therapy. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lipton, A
  • Coleman, RE
  • Major, P
  • Brown, JE
  • Lee, KA
  • Smith, M
  • Saad, F
  • Chen, YM
  • Hei, YJ
  • Cook, Richard

publication date

  • November 16, 2005

published in